Moreover, others have suggested that, in colorectal and gastric cancers, CD4+ TReg cells may inhibit tumor-promoting inflammatory responses induced by local microbes, which may help explain their presence and favorable association with outcomes to these cancers (Haas et al., 2009; Zamarron and Chen, 2011). This evidence concerns the gene CD4 and cancer.